Dabigatran etexilate for the secondary prevention of stroke after an embolic stroke of undetermined source (ID1417)Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Invimestrocel for treating acute ischaemic stroke within 18 to 36 hours of onset TS ID 10190Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC